Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 7/20 | 0.71 |
| ▸ | CES1 | P23141 | 7/20 | 0.71 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ASPH | Q12797 | 1/20 | 0.41 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | ALB | P02768 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TTR | P02766 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6138722 | 0.87 | CES2 (0.56) | CES2CES1KEAP1KDM4EASPH | |
| SCHEMBL9693312 | 0.83 | CES2 (0.74) | CES2CES1KEAP1CA1CA2 | |
| SCHEMBL477822 | 0.81 | CES2 (0.71) | CES2CES1KEAP1CA1CA2 | |
| SCHEMBL29695966 | 0.79 | AKR1C2 (0.58) | CES2CES1KEAP1KDM4EASPH | |
| SCHEMBL2791251 | 0.79 | AKR1C2 (0.58) | CES2CES1KEAP1KDM4EASPH | |
| SCHEMBL16759605 | 0.79 | KDM4E (0.50) | CES2CES1KEAP1KDM4EASPH | |
| SCHEMBL8466122 | 0.79 | CES2 (0.50) | CES2CES1KEAP1KDM4EASPH | |
| SCHEMBL935368 | 0.79 | CA1 (0.45) | CES2CES1KEAP1KDM4EASPH | |
| SCHEMBL29467941 | 0.79 | CES2 (0.68) | CES2CES1CA1CA2ERN1 | |
| SCHEMBL363749 | 0.79 | CES2 (0.68) | CES2CES1CA1CA2ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113956877-A | Preparation of organic fluorine-containing carbon quantum dot with near-infrared excitation/emission property | 重庆医科大学 | 2022-01-21 | — | — | CN | claimed |
| CN-107681052-B | Main group metal complexes as p-dopants for organic electronic matrix materials | 西门子公司 | 2020-03-24 | — | — | CN | claimed |
| US-10483466-B2 | P-doping cross-linking of organic hole transporters | SIEMENS AKTIENGESELLSCHAFT (DE) | 2019-11-19 | — | — | US | claimed |
| EP-3114715-B1 | P-DOPING CROSS-LINKING OF ORGANIC HOLE TRANSPORTERS | SIEMENS AG (DE) | 2019-10-30 | — | — | EP | claimed |
| US-20180198069-A1 | P-Doping Cross-Linking Of Organic Hole Transporters | SIEMENS AKTIENGESELLSCHAFT (DE) | 2018-07-12 | — | — | US | claimed |
| CN-107681052-A | The main group metal complex compound of p dopants as organic electronic matrix material | 西门子公司 | 2018-02-09 | — | — | CN | claimed |
| EP-3057151-B1 | BISMUTH AND TIN COMPLEXES AS P DOTANDS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | SIEMENS AG (DE) | 2018-01-31 | — | — | EP | claimed |
| US-20170098787-A1 | MAIN GROUP METAL COMPLEXES AS P-DOPANTS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | SIEMENS AKTIENGESELLSCHAFT (DE) | 2017-04-06 | — | — | US | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| US-7410011-B2 | Method to determine the concentration of deuterium oxide in a subterranean formation | CORE LABORATORIES LP (US) | 2008-08-12 | — | — | US | claimed |
| US-20070215385-A1 | Method to determine the concentration of deuterium oxide in a subterranean formation | CORE LABORATORIES LP (US) | 2007-09-20 | — | — | US | claimed |
| US-20060144588-A1 | Method for determining tracer concentration in oil and gas production fluids | CORE LABORATORIES LP (US) | 2006-07-06 | — | — | US | claimed |
| WO-2006047478-A2 | METHOD FOR DETERMINING TRACER CONCENTRATION IN OIL AND GAS PRODUCTION FLUIDS | CORE LABORATORIES, L.P. (US) | 2006-05-04 | — | — | WO | claimed |
| US-7032662-B2 | Method for determining the extent of recovery of materials injected into oil wells or subsurface formations during oil and gas exploration and production | CORE LABORATORIES LP (US) | 2006-04-25 | — | — | US | claimed |
| US-20040094297-A1 | Method for determining the extent of recovery of materials injected into oil wells or subsurface formations during oil and gas exploration and production | CORE LABORATORIES LP | 2004-05-20 | — | — | US | claimed |
| US-6659175-B2 | Mixing water, buffers, oxidizers, gels, gelation inhibitors, stabilizer and curing agents with tracers, then pumping the mixtures into bores, withdrawing fluids and measuring concentration of labels; well completion efficiency | CORE LABORATORIES, INC. | 2003-12-09 | — | — | US | claimed |
| US-20030006036-A1 | Mixing water, buffers, oxidizers, gels, gelation inhibitors, stabilizer and curing agents with tracers, then pumping the mixtures into bores, withdrawing fluids and measuring concentration of labels; well completion efficiency | CORE LABORATORIES GLOBAL N.V. (NL) | 2003-01-09 | — | — | US | claimed |
| WO-2002095189-A1 | METHOD OF DETERMINING THE EXTENT OF RECOVERY OF MATERIALS INJECTED INTO OIL WELLS | CORE LABORATORIES L.P. (US) | 2002-11-28 | — | — | WO | claimed |
| US-5336806-A | Forming salt with hydroxide, precipitating, filtering, washing, dissolving, passing over activated carbon, and adding strong mineral acid | OCCIDENTAL CHEMICAL CORPORATION (US) | 1994-08-09 | — | — | US | claimed |
| US-H992-H | Using copper catalyst in quinoline or n-methyl-2-pyrrolidone | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-11-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170098787-A1 | MAIN GROUP METAL COMPLEXES AS P-DOPANTS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | SCO2, SOD3, NCOA3 | CES2 3153/4885CES1 3684/4885KEAP1 907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.